Oaktree Acquisition III Life Sciences Q2 FY26 net income drops to $1.6 million
OACC•Trust account and cash position
Cash held in the trust account was $205.28 million at June 30, 2026, with $1.18 million held outside the trust.
Second-quarter and six-month results
Oaktree Acquisition III Life Sciences posted net income of $1.6 million for the three months ended June 30, 2026.
Earnings fell 14.38% year over year on interest income of $1.87 million, offset by general and administrative costs of $261,958.
Six-month net income slipped 15.12% to $3 million, reflecting interest income of $3.72 million.
General and administrative expenses totaled $718,496 for the six-month period, while operating cash outflow was $255,295.
